LeMaitre Vascular (LMAT) Insider Exercises Options and Sells Shares on 08/11/2025
Rhea-AI Filing Summary
LeMaitre Vascular President and Director David B. Roberts reported option exercises and subsequent open-market sales on 08/11/2025. The Form 4 shows Mr. Roberts acquiring shares upon exercise of previously granted stock options and selling multiple blocks of common stock the same day.
The filing lists option exercises generating 3,979, 123 and 6,713 shares at exercise prices of $37.29 and $35.48. On 08/11/2025 he sold blocks of 3,718, 384 and 6,713 shares at weighted average prices of $92.5337, $91.5484 and $92.3549, respectively. The filing shows beneficial ownership of 17,976 shares following these transactions. The Form is signed by Nathan Ulrich on 08/13/2025 as submitted.
Positive
- Timely and detailed disclosure of option exercises and sales on Form 4, including weighted average prices and share counts
- Continued direct ownership is reported: the filing shows the reporting person still holds 17,976 shares after the transactions
Negative
- Substantial open-market sales on 08/11/2025 totaling 10,815 shares (3,718 + 384 + 6,713), reducing insider holdings
- Exercises followed by immediate sales on the same date, which reduced beneficial ownership from higher interim levels to 17,976 shares
Insights
TL;DR: Routine option exercises followed by same-day sales; total sale volume and final holdings are disclosed.
The Form 4 documents exercises of vested and partially vested options and concurrent open-market dispositions on 08/11/2025. The transactions include option exercises at strikes of $35.48 and $37.29 and sales at weighted average prices around $91.55–$92.53. These filings are material for transparency and show a reduction in insider beneficial ownership to 17,976 shares. The disclosure is timely and quantifies both the acquired and sold share counts and prices.
TL;DR: Insider complied with Section 16 reporting; exercises and sales occurred the same date, reducing holdings.
The reporting person, identified as President and Director, filed a Form 4 reporting multiple option exercises and subsequent sales on the same date (08/11/2025). The filing specifies exact share counts, exercise prices, weighted average sale prices and resulting beneficial ownership (17,976 shares). From a governance perspective, the document provides required transparency but reflects a net decrease in the officer's direct stock position after the transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 123 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 3,979 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 6,713 | $0.00 | -- |
| Exercise | Common Stock | 3,979 | $37.29 | $148K |
| Exercise | Common Stock | 123 | $35.48 | $4K |
| Sale | Common Stock | 3,718 | $92.5337 | $344K |
| Sale | Common Stock | 384 | $91.5484 | $35K |
| Exercise | Common Stock | 6,713 | $37.29 | $250K |
| Sale | Common Stock | 6,713 | $92.3549 | $620K |
Footnotes (1)
- Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.91 to $92.91. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.38 to $91.89. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $92.045 to $93.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. This option is fully vested and exercisable. This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.
